Genetesis

Genetesis LLC is a Cincinnati-based company that is revolutionizing the standard of care for ischemic heart disease with their groundbreaking CardioFlux technology. By measuring and displaying the magnetic signals produced by the electric currents in the heart, CardioFlux enables the detection of functionally significant ischemia at its earliest stages, providing rapid and dynamic results in as little as 5 minutes. With their non-invasive and fast approach, Genetesis is bringing 40 years of proven science into hospital workflows, offering a more efficient and effective solution for cardiac imaging.

Partnering with leading physicians and medical institutions, Genetesis is building a better standard of care by combining trusted science with brand new technology. Their CardioFlux pathway promises diagnostic certainty without the burden, allowing for significantly earlier detection of chest pain patients and reducing the time spent testing and waiting for results. With physician testimonials praising the non-invasive nature and effectiveness of CardioFlux, Genetesis is poised to transform the field of cardiac imaging and improve patient outcomes.

Generated from the website